Taylor P
Key Pharmacokinetic Parameters The table below describes the key pharmacokinetic parameters for DPP-4 inhibitors: Cautions and contraindications Cautions and contraindications for the use of DPP-4 inhibitors are listed below: Adverse effects Other adverse effects include: Increased risk of infection with saxagliptin, alogliptin and vildagliptin Hypersensitivity reactions (including anaphylaxis, angioedema, stevens-johnson syndrome) Sitagliptin: interstitial lung disease, impaired renal function, thrombocytopenia, and acute renal failure
You will learn about potential side effects, which may include mild nausea, gastrointestinal changes, or injection-site reactions, particularly during the early weeks as your body adjusts
A product sold under that nickname has not necessarily been manufactured by Lilly, verified as retatrutide, or reviewed by the FDA
However, the views and opinions expressed are those of the individual authors or content creators and are not influenced by compensation
Furthermore, in the EMPA-REG OUTCOME trial, empagliflozin reduced the risk of both pump failure and sudden deaths (46)